afm-24
affimed
['afm24']
 #asco22 | omar saavedra is delivering two presentations to explain the design and rationale behind the first clinical trials in humans with afm24, a bi-specific antibody capable of enhancing immune response. 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre